Cumberland Pharmaceuticals (CPIX) Receivables - Net (2016 - 2025)
Cumberland Pharmaceuticals (CPIX) has disclosed Receivables - Net for 16 consecutive years, with $16.9 million as the latest value for Q4 2025.
- Quarterly Receivables - Net rose 44.81% to $16.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.9 million through Dec 2025, up 44.81% year-over-year, with the annual reading at $16.9 million for FY2025, 44.81% up from the prior year.
- Receivables - Net hit $16.9 million in Q4 2025 for Cumberland Pharmaceuticals, up from $10.4 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $16.9 million in Q4 2025 to a low of $6.9 million in Q4 2021.
- Historically, Receivables - Net has averaged $11.9 million across 5 years, with a median of $11.7 million in 2024.
- Biggest YoY gain for Receivables - Net was 110.92% in 2021; the steepest drop was 44.44% in 2021.
- Year by year, Receivables - Net stood at $6.9 million in 2021, then surged by 91.41% to $13.2 million in 2022, then fell by 25.87% to $9.8 million in 2023, then rose by 19.91% to $11.7 million in 2024, then surged by 44.81% to $16.9 million in 2025.
- Business Quant data shows Receivables - Net for CPIX at $16.9 million in Q4 2025, $10.4 million in Q3 2025, and $10.3 million in Q2 2025.